PMEL (25-33)

PMEL (25-33) is a synthetic peptide corresponding to amino acid residues 25 to 33 of the premelanosome protein (PMEL), a melanocyte-specific glycoprotein critical in the formation of functional melanosomes. As a well-defined segment of the PMEL protein, this peptide is widely recognized for its role in studies of melanosome biogenesis, amyloid fibril formation, and antigen processing. Its defined sequence and biochemical properties make it a valuable tool in peptide research, particularly in the context of pigmentation biology, immunology, and protein aggregation studies.

Epitope mapping: PMEL (25-33) is frequently utilized in epitope mapping experiments to identify and characterize T-cell and B-cell recognition sites within the PMEL protein. By providing a precise peptide fragment, researchers can dissect immune responses targeting melanocyte antigens, which is particularly relevant in studies of autoimmune pigmentation disorders and in the development of immunological assays for antigen-specific T cell responses.

Antigen presentation studies: The peptide serves as a model substrate for investigating antigen processing and presentation by major histocompatibility complex (MHC) molecules. Its sequence is known to be presented by certain MHC class I alleles, making it instrumental in elucidating the molecular mechanisms underlying peptide loading, immunodominance, and T-cell activation. These insights are essential for understanding immune surveillance in melanocyte biology and tumor immunology.

Peptide aggregation and amyloidogenesis research: PMEL (25-33) is a valuable tool for probing the mechanisms of peptide aggregation and amyloid fibril formation, as the PMEL protein is one of the few physiological amyloids found in mammals. The peptide segment allows researchers to study the nucleation and elongation phases of amyloid formation in vitro, offering mechanistic insight into the self-assembly processes that underpin functional and pathological amyloidogenesis.

Melanosome biogenesis models: The defined sequence of PMEL (25-33) enables its use in model systems probing melanosome maturation and the structural determinants of fibril formation within pigment cells. By incorporating this peptide into experimental protocols, investigators can assess its impact on melanosome morphology, protein-protein interactions, and the assembly of the internal matrix, advancing understanding of pigmentation biology at the molecular level.

Peptide synthesis and assay development: As a well-characterized peptide, PMEL (25-33) is employed as a reference standard or control in peptide synthesis workflows and analytical assay development. Its predictable chemical properties and biological relevance support method validation, quality control, and the optimization of mass spectrometry or chromatographic techniques for peptide identification and quantification in complex biological samples.

1. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

2. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

4. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

5. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis